Ligand validation:2VG1

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2VG1_GOL_B_1261	40%	70%	0.177	0.888	0.53	0.59	-	-	3	0	100%	1
2VG1_GOL_B_1258	20%	89%	0.267	0.87	0.36	0.28	-	-	0	0	100%	1
2VG1_GOL_B_1259	13%	71%	0.259	0.8	0.53	0.56	-	-	0	0	100%	1
2VG1_GOL_A_1258	12%	79%	0.284	0.814	0.35	0.5	-	-	0	0	100%	1
2VG1_GOL_A_1259	8%	79%	0.217	0.681	0.47	0.38	-	-	0	0	100%	1
2VG1_GOL_B_1260	2%	92%	0.375	0.666	0.35	0.17	-	-	0	0	100%	1
2VG0_GOL_B_1258	37%	91%	0.198	0.894	0.35	0.22	-	-	0	0	100%	1
1SSX_GOL_A_249	100%	72%	0.032	0.994	0.64	0.43	-	-	0	0	100%	0.8
4CJ0_GOL_A_1582	100%	73%	0.037	0.994	0.7	0.35	-	-	0	0	100%	1
7T8M_GOL_A_401	100%	41%	0.039	0.991	1.21	1.14	-	-	0	0	100%	1
4UQL_GOL_Q_1553	100%	89%	0.04	0.991	0.35	0.29	-	-	0	0	100%	1
8A3H_GOL_A_601	100%	92%	0.041	0.989	0.27	0.27	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.